EDCTP supports all phases of clinical trials, as well as product-focused implementation research, with a focus on phase II and III clinical trials, for new or improved medical intervention against poverty-related infectious diseases, including advanced testing and field validation of new diagnostic tools.

Poverty-related infectious diseases covered by EDCTP

HIV, tuberculosis, malaria, neglected infectious diseases (Buruli ulcer, cysticercosis/taeniasis, chikungunya, dengue, dracunculiasis, echinococcosis, foodborne trematodiases, leprosy (Hansen disease), human African trypanosomiasis, leishmaniases, lymphatic filariasis, mycetoma, onchocerciasis, rabies, schistosomiasis, soil-transmitted helminthiases, trachoma, yaws); diarrhoeal diseases; lower respiratory tract infections, as well as emerging or re-emerging infectious diseases of particular relevance for Africa, such as Ebola virus disease or yellow fever.